Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer

類似資料

• The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R
  著者:: Zhong, Diansheng, 等
  出版事項: (2009)
• Corrigendum to “Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression” [Lung Cancer 88/2 (2015) 131–138]
  著者:: Mao, Kaisheng, 等
  出版事項: (2021)
• Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression
  著者:: Mao, Kaisheng, 等
  出版事項: (2015)
• 2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells
  著者:: Sun, Linlin, 等
  出版事項: (2016)
• LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions
  著者:: Liu, Fakeng, 等
  出版事項: (2015)